Home

Julie Krop

CIK 1643127 · Chief Medical Officer · last filed 2026-06-24

Julie Krop is a Chief Medical Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for AQST, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$293.7K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$293.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AQST Director 0 $3.76 $0 -$125.4K 8 2026-06-24
DMAC Chief Medical Officer — $6.64 — $0 2 2026-06-03
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted Chief Medical Officer 73,044 — — -$168.4K 16 2020-03-04

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 AQST Mixed — -$107.6K EDGAR
2026-06-23 AQST Notice (144) −25,000 -$118.0K EDGAR
2026-06-12 AQST Grant (A) — $0 EDGAR
2026-06-03 DMAC Grant (A) — $0 EDGAR
2025-11-03 DMAC Grant (A) — $0 EDGAR
2025-06-12 AQST Grant (A) — $0 EDGAR
2024-06-21 AQST Grant (A) — $0 EDGAR
2023-06-23 AQST Grant (A) — $0 EDGAR
2022-06-24 AQST Grant (A) — $0 EDGAR
2021-06-17 AQST Grant (A) — $0 EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.